| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | US20020035251 Antiproliferative agents |
| 03/21/2002 | US20020035106 Use of potassium channel agonists for reducing fat food consumption |
| 03/21/2002 | US20020035030 Contacting alpha-olefin with ransition metal complex of and Bronsted or Lewis acid to produce polyolefin |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1187838A1 Thiazolopyrimidines useful as tnf-alpha inhibitors |
| 03/20/2002 | EP1187837A1 Thiazepine inhibitors of hiv-1 integrase |
| 03/20/2002 | EP1187836A1 Substituted imidazothiazoles as antidepressant agents |
| 03/20/2002 | CN1341109A Polycyclic thiazole-2-ylides amines, process for the production thereof and their utilization as medicaments |
| 03/19/2002 | US6358885 Preemergent or postemergent herbicides or plant growth regulants |
| 03/19/2002 | CA2128359C New benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |
| 03/14/2002 | US20020032325 4-amino-3-mercapto-1,2,4-triazoles |
| 03/14/2002 | US20020032196 CRF receptor antagonists and methods relating thereto |
| 03/13/2002 | EP1185535A1 Cyclocarbamate and cyclic amide derivatives |
| 03/13/2002 | EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 03/07/2002 | WO2001062765A3 Small molecule modulators of g protein-coupled receptor six |
| 03/07/2002 | US20020028823 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same |
| 03/07/2002 | US20020028808 Use of potassium channel agonists for the treatment of cancer |
| 03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP0876372B1 Heteroarylcarboxamide derivatives |
| 03/06/2002 | EP0843681B1 Heterocycle-fused thiazole derivatives |
| 03/06/2002 | CN1339038A Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 03/06/2002 | CN1080258C 1-H-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents |
| 03/05/2002 | US6352958 Pre- and post-emergence herbicides |
| 02/28/2002 | WO2001058837A3 Process for the preparation of (r)-2-bromo-3-phenyl-propionic acid |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | US20020025976 Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/28/2002 | US20020025960 Heterocycle carboxamides as antiviral agents |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/27/2002 | EP1181283A1 Diaminothiazoles and their use for inhibiting protein kinases |
| 02/27/2002 | EP1181282A2 Benzothiazinone and benzoxazinone compounds |
| 02/27/2002 | EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/26/2002 | US6350881 Process for the preparation of 5-methoxy-4-(methylthioalkyl) 1, 3-bis(phenylmethyl)-2-imidazolidone |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350743 Cytotoxic pyridoacridine alkaloids |
| 02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/21/2002 | WO2002014321A1 Use of stat-6 inhibitors as therapeutic agents |
| 02/21/2002 | WO2002014295A1 Thiazine derivatives having antibacterial and antiviral action |
| 02/21/2002 | WO2002013834A1 Nocathiacin antibiotics prepared by biotransformation or chemical methods |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | WO2001079187A3 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 02/21/2002 | WO2001058904A9 Apoptosis-inducing compounds |
| 02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 02/21/2002 | US20020022635 For therapy of cancer; inflammation; an autoimmune, infectious or ocular disease; or age-related macular degeneration |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP0934079B1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes |
| 02/19/2002 | US6348457 Antagonizing reserpine in mammals |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012212A1 Di(het)arylaminothiazole derivatives and their use in organic light-emitting diodes (oled's) and organic photovoltaic components |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | US20020019531 Indoles |
| 02/14/2002 | US20020019425 Anticancer agents; administering p53 gene or protein |
| 02/14/2002 | US20020018912 Transistors, liquid crystal display, electrooptics |
| 02/14/2002 | CA2420967A1 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | CA2411928A1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclindependent kinases |
| 02/13/2002 | EP1178993A1 Thiazoloderiatives and pharmaceutical compositions containing them |
| 02/13/2002 | EP1178992A2 Process for the preparation of cefpodoxime acid |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/12/2002 | US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants |
| 02/12/2002 | US6346531 G-CSF mimetics |
| 02/07/2002 | WO2002010175A1 PYRROLO[2,1-b][1,3]BENZOTHIAZEPINES AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS WITH ANTIPSYCHOTIC ACTIVITY |
| 02/07/2002 | WO2002010174A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines |
| 02/07/2002 | US20020016475 Does not require high pressure or temperature, not susceptible to air or sulfur poison; easy to handle |
| 02/07/2002 | US20020016460 Pyridine -imidazole, -thiazole or -oxazole derivatives; treating autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer |
| 02/07/2002 | US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 02/05/2002 | CA2343023C Process for preparing nizatidine utilizing toluene as solvent |
| 01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers |
| 01/31/2002 | US20020013313 4,5-dihydro-1,3-dithia-4-aza-acenaphthylene-3,3-dioxide compounds for example; treating ischemia, Alzheimer's disease, schizophrenia; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) |
| 01/31/2002 | DE10034803A1 Substituierte Sulfonsäureanilide Substituted Sulfonsäureanilide |
| 01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
| 01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/30/2002 | EP1176148A1 Benzothiadiazine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333087A Ferrocence ruthenium phosphide complex and method for preparing d-thilane by exocyclic double-bond hydrogenation of d-thiophene using said complex as catalyst |
| 01/29/2002 | US6342490 Antiproliferation of cells |
| 01/24/2002 | WO2002006288A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | WO2002006244A1 Heterocyclic substituted herbicidal sulphonic acid anilides |
| 01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | US20020010169 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 01/24/2002 | CA2416384A1 Sulfone derivatives, their production and use |
| 01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173427A1 Hydroxamic acid derivative |
| 01/23/2002 | EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |